Influence of antidepressant use on glycemic control in patients with diabetes mellitus: An open-label comparative study

Journal of Clinical Psychopharmacology

Volumn 29, Issue 4, 2009, Pages 405-408

  Derijks, Hieronymus J ^a   Janknegt, Robert ^b   Heerdink, Eibert R ^a   De Koning, Fred H P ^a,c   Krekels, Marielle M ^b   Looij, Bert Jan ^b   Egberts, Antoine C G ^a,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

^c Kring Apotheken Nederland   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; HEMOGLOBIN A1C; INSULIN; METFORMIN; PAROXETINE; SERTRALINE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG MECHANISM; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CITALOPRAM; DEPRESSION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 68449104267     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181acd0ac     Document Type: Letter

References (10)

1. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069-1078.
2. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of literature. Diabetes Care. 2000;23:934-942.
3. Derijks HJ, Meyboom RH, Heerdink ER, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol. 2008;64:531-538.
4. Derijks HJ, Heerdink ER, De Koning GH, et al. Visualizing pharmacological activities of antidepressant: a novel approach. Open Pharmacol J. 2008;2:54-62.
5. Pandit MK, Burke J, Gustafson AB, et al. Drug-induced disorders of glucose tolerance. Ann Intern Med. 1993;118:529-539.
6. Potter van Loon BJ, Radder JK, Frolich M, et al. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord. 1992;16:79-85.
7. Scheen AJ, Paolisso G, Salvatore T, et al. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine. Diabetes Care. 1991;14:325-332.
8. Knol MJ, Derijks HJ, Geerlings MI, et al. Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiol Drug Saf. 2008;17:577-586.
9. Weber-Hamann B, Gilles M, Lederbogen F, et al. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. J Clin Psychiatry. 2006;67:1856-1861.
10. Pollak PT, Mukherjee SD, Fraser AD. Sertraline-induced hypoglycemia. Ann Pharmacother. 2001;35:1371-1374.